Bolarinwa, Obasanjo ORCID: https://orcid.org/0000-0002-9208-6408, Nwagbara, Ugochinyere Ijeoma, Okyere, Joshua, Ahinkorah, Bright Opoku, Seidu, Abdul-Aziz ORCID: https://orcid.org/0000-0001-9734-9054, Ameyaw, Edward Kwabena and Igharo, Victor (2021) Prevalence and predictors of long-acting reversible contraceptive use among sexually active women in 26 sub-Saharan African countries. International Health, 14 (5). pp. 492-500.

Preview

Text ihab053.pdf - Published Version Available under License Creative Commons Attribution. Download (323kB) | Preview

Abstract

Background
Long-acting reversible contraceptives (LARCs) are associated with high efficacy rates and continuity of use. Based on the foregoing, we sought to examine the prevalence and factors associated with LARC use among sexually active women in 26 countries in sub-Saharan Africa(SSA).

Methods
Secondary data from Demographic and Health Surveys conducted in 26 countries in SSA between January 2010 and December 2019 were pooled and analysed. A total of 56 067 sexually active women 15–49 y of age met the inclusion criteria. Bivariate and multivariate regression analyses were performed to examine the association between selected factors and the use of LARCs in SSA. Results were presented as crude odds ratios and adjusted odds ratios (aORs) with statistical precision at <0.05.

Results
The prevalence of LARC use was 21.73%, ranging from 1.94% in Namibia to 54.96% in Benin. Sexually active women with secondary or higher education (aOR 1.19 [95% confidence interval {CI} 1.08 to 1.32]), those cohabiting (aOR 1.25 [95% CI 1.06 to 1.47]) and those with four or more children (aOR 2.22 [95% CI 1.78 to 2.78]) were more likely to use LARCs compared with those without education, never married and with no biological child.

Conclusions
The use of LARCs in the 26 countries in SSA was relatively low. Hence, the identified contributory factors of LARC use should be tackled with appropriate interventions. These include continuous campaigns on the efficacy of LARCs in reducing unintended pregnancy, maternal mortality and morbidity.

Item Type:	Article
Status:	Published
DOI:	10.1093/inthealth/ihab053
School/Department:	London Campus
URI:	https://ray.yorksj.ac.uk/id/eprint/8501

University Staff: Request a correction | RaY Editors: Update this record